Branning Todd P.
Insider CIK 1765274 · NBSE Chief Financial Officer · AMRX SVP, Chief Financial Officer · PHAT Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBSE NeuBase Therapeutics, Inc. | A Award | 2023-03-16 | 2023-03-17 | 54,200 | — | $0 | 84,200 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2022-11-03 | 2022-11-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2022-03-18 | 2022-03-21 | 10,000 | $1.81 | $18.1K | 30,000 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2022-03-17 | 2022-03-18 | 10,000 | $1.74 | $17.4K | 20,000 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2022-03-16 | 2022-03-18 | 10,000 | $1.62 | $16.2K | 10,000 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2022-01-10 | 2022-01-10 | 300,000 | — | $0 | 300,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2021-01-28 | 2021-01-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2020-07-13 | 2020-07-13 | 85,000 | — | $0 | 85,000 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2020-02-27 | 2020-03-02 | 83,113 | — | $0 | 83,113 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2020-02-27 | 2020-03-02 | 166,226 | — | $0 | 166,226 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2020-01-22 | 2020-01-23 | 20,096 | — | $0 | 60,290 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2020-01-22 | 2020-01-23 | 7,311 | $5.13 | $37.5K | 12,785 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2020-01-22 | 2020-01-23 | 20,096 | — | $0 | 20,096 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-11-13 | 2019-11-14 | 163,666 | — | $0 | 163,666 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | D To issuer deriv | 2019-11-13 | 2019-11-14 | 163,666 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-01-22 | 2019-01-24 | 80,386 | — | $0 | 80,386 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-01-22 | 2019-01-24 | 163,666 | — | $0 | 163,666 | SEC↗ |